chr11-77156908-C-G

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_000260.4(MYO7A):ā€‹c.639C>Gā€‹(p.Phe213Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

11
4
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: -1.23
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.985

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO7ANM_000260.4 linkuse as main transcriptc.639C>G p.Phe213Leu missense_variant 7/49 ENST00000409709.9 NP_000251.3 Q13402-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkuse as main transcriptc.639C>G p.Phe213Leu missense_variant 7/491 NM_000260.4 ENSP00000386331.3 Q13402-1
MYO7AENST00000458637.6 linkuse as main transcriptc.639C>G p.Phe213Leu missense_variant 7/491 ENSP00000392185.2 Q13402-2
MYO7AENST00000409619.6 linkuse as main transcriptc.606C>G p.Phe202Leu missense_variant 8/501 ENSP00000386635.2 Q13402-8

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461680
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727124
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Apr 13, 2021- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 10, 2020In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with MYO7A-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces phenylalanine with leucine at codon 213 of the MYO7A protein (p.Phe213Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
13
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.97
D;D;.;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.51
FATHMM_MKL
Benign
0.22
N
LIST_S2
Uncertain
0.90
D;D;D;D
M_CAP
Pathogenic
0.46
D
MetaRNN
Pathogenic
0.99
D;D;D;D
MetaSVM
Uncertain
0.28
D
MutationAssessor
Pathogenic
4.1
H;.;H;.
PrimateAI
Pathogenic
0.93
D
PROVEAN
Pathogenic
-5.1
D;.;D;D
REVEL
Pathogenic
0.67
Sift
Pathogenic
0.0
D;.;D;D
Sift4G
Uncertain
0.0050
D;D;D;D
Polyphen
1.0
D;.;.;.
Vest4
0.99
MutPred
0.93
Gain of MoRF binding (P = 0.114);Gain of MoRF binding (P = 0.114);Gain of MoRF binding (P = 0.114);.;
MVP
0.79
MPC
0.50
ClinPred
1.0
D
GERP RS
-5.7
Varity_R
0.96
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs540197003; hg19: chr11-76867954; API